A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 168 participants.
Also called NCT01135433
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 168 participants
- Sponsor
- Registry
-
NCT01135433
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01135433. Randomized; quadruple masking; primary purpose treatment. Start 2010-05-15 (actual); primary completion 2011-11-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- ipragliflozin
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- metformin
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01135433- Content hash
fb580b9721fba1fbc8233e3396e0a81f6ca4730a770591c8392f809775e1c8cd